Zulvac SBV

RSS

Inactivated Schmallenberg virus, strain BH80/11-4

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Zulvac SBV. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Zulvac SBV.

For practical information about using Zulvac SBV, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 11/04/2017

Authorisation details

Product details
Name
Zulvac SBV
Agency product number
EMEA/V/C/002781
Active substance
Inactivated Schmallenberg virus, strain BH80/11-4
International non-proprietary name (INN) or common name
Inactivated Schmallenberg virus, strain BH80/11-4
Species
  • Cattle
  • Sheep
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI02AA
Publication details
Marketing-authorisation holder
Zoetis Belgium SA
Revision
2
Date of issue of marketing authorisation valid throughout the European Union
06/02/2015
Contact address
Rue Laid Burnait, 1
1348 Louvain-la-Neuve
Belgium

Product information

23/03/2017 Zulvac SBV - EMEA/V/C/002781 - IG/0747

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Immunologicals for bovidae
  • inactivated viral vaccines for cattle

Therapeutic indication

For active immunisation of cattle and sheep from 3.5 months of age to prevent viraemia associated with infection by Schmallenberg virus.

Assessment history

How useful was this page?

Add your rating
Average
37 ratings
39 ratings
43 ratings
35 ratings